BTIG maintains Buy rating for Humacyte, lowers PT to $3 from $6.

viernes, 27 de marzo de 2026, 10:50 am ET1 min de lectura
HUMA--

BTIG maintains Buy rating for Humacyte, lowers PT to $3 from $6.

BTIG maintains Buy rating for Humacyte, lowers PT to $3 from $6.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios